The Globalization of Innovation: Can India and China Cure the Global Pharmaceutical Market?

The Globalization of Innovation: Can India and China Cure the Global Pharmaceutical Market?
Year:
Listing Type: Publications

Vivek Wadhwa | Ben Rissing | Gary Gereffi | John Trumpbour | Pete Engardio

Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These relationships largely appear to be symbiotic. As a result of the movement of research to their countries, Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments of the pharmaceutical global value chain. This research was funded in part by the Ewing Marion Kauffman Foundation.

Geography: Asia
Client:
Industry:
View Article on SSRN

Subscribe:

Stay up to date with Duke GVC Center research – subscribe to our monthly newsletter